Answers are grounded in this paper and cite their sources.
Emerging evidence suggests that anesthesia can modulate natural killer (NK) cell activity, potentially influencing anti-tumor immunity. In this randomized study, 14 patients undergoing laparoscopic colorectal cancer surgery received an immune-protective anesthetic strategy (propofol/epidural/dexmedetomidine) or a conventional strategy (sevoflurane/opioids). Peripheral blood mononuclear cells (PBMCs) were collected preoperatively and at 24 and 48 h postoperatively. CD56+CD16+ NK-cell subsets were characterized by flow cytometry based on NKG2A, NKG2C, and KIR expression. Cytotoxic potential was assessed by intracellular perforin and granzyme B, and CD107a expression as a degranulation marker. Significant decreases from 0 to 48 h were observed in the conventional group for NKG2A+KIR+ double-positive (DP) NK cells (−0.69 percentage points, p = 0.02) and terminally differentiated (NKG2A−NKG2C−) NK cells (−2.22 percentage points, p = 0.02). CD107a expression in DP NK cells increased at 48 h versus baseline (+44.9% MFI, p = 0.04) only in the conventional group. Intracellular granzyme B (−3.38 percentage points; p = 0.02) and perforin levels (−4.56 percentage points, p = 0.04) decreased from 0 to 48 h in the conventional group. These findings suggest that an immune-protective anesthetic strategy may better preserve NK cell subset distribution and cytotoxic potential. However, given the modest magnitude of changes, these results should be interpreted as exploratory.
No takes yet. Share an insight, caveat, or question.
Knijff et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: